In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Editorial - April 2020

ESC Working Group on Cardiovascular Pharmacotherapy

Dear members of the ESC WG on Cardiovascular Pharmacotherapy,

We regret to inform you that EuroCVP 2020, scheduled for 28-29 May, will not take place as planned.

As the novel coronavirus (COVID–19) has been spreading throughout Europe and beyond, it has prevented many of you from travelling. In addition, the Austrian government has taken preventive measures and prohibited events there until the end of June. Although deeply disappointing, we could not proceed with the courses to be held on site. Your health and safety are of the greatest priority to us.

For the time being, we are maintaining our next courses in October and December this year, and look forward to the next opportunity to meet and network with you all.

Rght now, we focus on print publications from the WG. Our handbook is just being updated to a new electronic version, Professors Kjeldsen and Kaski work intensively together with all authors. Also, many original articles and review papers are in development by the WG.

Dear members, I have a further wish and request for you. Please recruit more members for the WG, we are approaching the 800 number earlier than expected, a wonderful achievement. Here our WG well could be at the forefront, particularly with increasing member counts. Please engage to encourage your friends and colleagues to apply for Membership.

Most importantly, take care and stay healthy at this difficult time.

With best regards

Heinz Drexel, MD

Chairman 2018-2020

ESC WG on Cardiovascular Pharmacotherapy

 

Back to other news from the ESC Working Group on Cardiovascular Pharmacotherapy